Literature DB >> 25023924

Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Richard P Allen1, Daniel L Picchietti2, Diego Garcia-Borreguero3, William G Ondo4, Arthur S Walters5, John W Winkelman6, Marco Zucconi7, Raffaele Ferri8, Claudia Trenkwalder9, Hochang B Lee10.   

Abstract

BACKGROUND: In 2003, following a workshop at the National Institutes of Health, the International Restless Legs Syndrome Study Group (IRLSSG) developed updated diagnostic criteria for restless legs syndrome/Willis-Ekbom disease (RLS/WED). These criteria were integral to major advances in research, notably in epidemiology, biology, and treatment of RLS/WED. However, extensive review of accumulating literature based on the 2003 NIH/IRLSSG criteria led to efforts to improve the diagnostic criteria further.
METHODS: The clinical standards workshop, sponsored by the WED Foundation and IRLSSG in 2008, started a four-year process for updating the diagnostic criteria. That process included a rigorous review of research advances and input from clinical experts across multiple disciplines. After broad consensus was attained, the criteria were formally approved by the IRLSSG executive committee and membership.
RESULTS: Major changes are: (i) addition of a fifth essential criterion, differential diagnosis, to improve specificity by requiring that RLS/WED symptoms not be confused with similar symptoms from other conditions; (ii) addition of a specifier to delineate clinically significant RLS/WED; (iii) addition of course specifiers to classify RLS/WED as chronic-persistent or intermittent; and (iv) merging of the pediatric with the adult diagnostic criteria. Also discussed are supportive features and clinical aspects that are important in the diagnostic evaluation.
CONCLUSIONS: The IRLSSG consensus criteria for RLS/WED represent an international, interdisciplinary, and collaborative effort intended to improve clinical practice and promote further research.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Consensus; Diagnosis; Movement disorder; Neurologic disorder; Restless legs syndrome; Sleep disorder; Willis–Ekbom disease

Mesh:

Year:  2014        PMID: 25023924     DOI: 10.1016/j.sleep.2014.03.025

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  294 in total

1.  Is Restless Legs Syndrome Involved in Ambulation Related to Sleepwalking?

Authors:  Régis Lopez; Yves Dauvilliers
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

2.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

3.  Executive and Visuospatial Dysfunction in Patients With Primary Restless Legs Syndrome/Willis-Ekbom Disease: Study of a Chinese Population.

Authors:  Gen Li; Huidong Tang; Jie Chen; Xuemei Qi; Shengdi Chen; Jianfang Ma
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 4.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

5.  Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis.

Authors:  Ann-Cathrine Dalgård Dunvald; Daniel Pilsgaard Henriksen; Jesper Hallas; Mette Marie Hougaard Christensen; Lars Christian Lund
Journal:  Eur J Clin Pharmacol       Date:  2020-02-16       Impact factor: 2.953

6.  Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life.

Authors:  Katharina A Schindlbeck; Janek Becker; Felix Berger; Arne Mehl; Charlotte Rewitzer; Sarah Geffe; Peter M Koch; Jan C Preiß; Britta Siegmund; Jochen Maul; Frank Marzinzik
Journal:  Int J Colorectal Dis       Date:  2016-10-18       Impact factor: 2.571

7.  Sleep dysfunction and its management in Parkinson's disease.

Authors:  Scott J Kutscher; Siavash Farshidpanah; Daniel O Claassen
Journal:  Curr Treat Options Neurol       Date:  2014-08       Impact factor: 3.598

Review 8.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

9.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

10.  Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.

Authors:  Allan Wang; Keyana Foster; Patrick Skeba; Kasidet Hiranniramol; Christopher J Earley; Richard P Allen
Journal:  Sleep Med       Date:  2018-08-17       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.